Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PTLD”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Early research (Phase 1)Not Yet RecruitingNCT06666153
What this trial is testing

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromePTLDs
West China Hospital 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06040320
What this trial is testing

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplant Lymphoproliferative Disorder
Washington University School of Medicine 12
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT02753062
What this trial is testing

Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Asan Medical Center 22
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01129180
What this trial is testing

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+9 more
Pierluigi Porcu 8
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT06954805
What this trial is testing

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
LymphomaLymphoma, B-Cell
Jennifer Amengual 30
Not applicableStudy completedNCT02182986
What this trial is testing

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Who this might be right for
Heart TransplantSmall Intestine TransplantKidney Transplant+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 944
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05688241
What this trial is testing

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Who this might be right for
EBV LymphomaPost-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Study completedNCT04156217
What this trial is testing

EBV-TCR-T Cells for EB Virus Infection After HSCT

Who this might be right for
EBV Emia and EBV Positive PTLD After Allogenic HSCT
Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00590447
What this trial is testing

Risk Stratified Sequential Treatment for CD20-positive PTLD

Who this might be right for
PTLDPosttransplant Lymphoproliferative Disorder
Charite University, Berlin, Germany 152
Large-scale testing (Phase 3)Study completedNCT00053053
What this trial is testing

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Who this might be right for
CachexiaLymphomaLymphoproliferative Disorder+1 more
Radiation Therapy Oncology Group 472
Testing effectiveness (Phase 2)Ended earlyNCT01458548
What this trial is testing

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Who this might be right for
Post-transplantation Lymphoproliferative Disorder
Charite University, Berlin, Germany 70
Next Page
30